P1: Dissecting high-risk bladder cancer/stroma evolution in an hPSC-based assembloid model

P2: Stratification of neuroendocrine pancreatic tumors by cell-type-of-origin and mutation

P3: Characterization, subtyping and therapeutic interference of biliary tract cancer

P4: Identification of the tumor-stroma interaction mechanisms involved in the development of chemoresistance using next-generation pancreatic cancer patient-derived assembloids

P5: Regulation of PDAC cancer stem cell plasticity, maintenance, and treatment-resistance by small extracellular vesicle-mediated intercellular communication in the PDAC tumor microenvironment

P6: New strategies for targeting the CXCR4 and ACKR3 axis in colorectal cancer

P7: Glucocorticoid receptor and RAS-dependent growth in lung tumors

P8: Uncovering breast cancer dormancy for developing novel therapies

P9: Single molecule studies of NOTCH transcriptional networks in pancreatic cancer

P10: Modelling disease progression and clonal evolution in CRC via Artificial Intelligence (AI)-based single-cell multiomics analyses